ResMed Inc (NYSE:RMD)
| 62.47 Data as of Jan 30 |  -0.56 / -0.89%Today’s Change | 41.52 Today|||52-Week Range 67.50 | +11.43% Year-to-Date |
Latest RMD News | Press Releases
| ResMed (RMD) Beats Q2 Earnings & Revenues, Margin Falls - Analyst Blog Jan 26 / Zacks.com | Long-term Account Review Jan 15 / StockTwits |
| Long-term Account Update Jan 23 / StockTwits | Happy New Year – And More 2015 Predictions Jan 02 / StockTwits |
| Will ResMed (RMD) Surprise Earnings Estimates in Q2? - Analyst Blog Jan 20 / Zacks.com |
Today’s Trading
| Previous close | 63.03 |
| Today’s open | 62.99 |
| Day’s range | 62.34 - 63.02 |
| Volume | 991,077 |
| Average volume (3 months) | 1,070,714 |
| Market cap | $8.8B |
| Dividend yield | 1.79% |
Data as of 4:03pm ET, 01/30/2015
Growth & Valuation
| Earnings growth (last year) | +13.81% |
| Earnings growth (this year) | +4.75% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +2.68% |
| P/E ratio | 25.4 |
| Price/Sales | 5.10 |
| Price/Book | 5.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VARVarian Medical Syste... | -1.48 | -1.57% |
| TFXTeleflex Inc | -2.31 | -2.06% |
| PCRXPacira Pharmaceutica... | -2.11 | -1.93% |
| THORThoratec Corp | -0.94 | -2.55% |
Data as of 6:27pm ET, 01/30/2015
Financials
| Last reporting date | January 22, 2015 |
| EPS forecast (this quarter) | $0.62 |
| Annual revenue (last year) | $1.6B |
| Annual profit (last year) | $345.3M |
| Net profit margin | 22.20% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Michael J. Farrell |
President & Chief Operating Officer Robert Andrew Douglas |
Corporate headquarters San Diego, California |
Forecasts
.